Fluvoxamine may prevent serious illness in COVID-19 patients, study suggests

Researchers have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.

Leave a Reply

Your email address will not be published. Required fields are marked *